Ensign Peak Advisors’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.97M Sell
125,633
-89,821
-42% -$4.83M 0.01% 475
2025
Q4
$10.4M Hold
215,454
0.02% 399
2025
Q3
$6.6M Hold
215,454
0.01% 542
2025
Q2
$4.78M Hold
215,454
0.01% 653
2025
Q1
$4.01M Hold
215,454
0.01% 685
2024
Q4
$2.85M Buy
215,454
+139,699
+184% +$3.38M 0.01% 804
2024
Q3
$2.54M Hold
75,755
﹤0.01% 848
2024
Q2
$1.9M Buy
75,755
+32,313
+74% +$752K ﹤0.01% 934
2024
Q1
$978K Hold
43,442
﹤0.01% 1335
2023
Q4
$931K Hold
43,442
﹤0.01% 1429
2023
Q3
$780K Hold
43,442
﹤0.01% 1385
2023
Q2
$884K Hold
43,442
﹤0.01% 1363
2023
Q1
$945K Hold
43,442
﹤0.01% 1286
2022
Q4
$1.35M Sell
43,442
-4,800
-10% -$136K ﹤0.01% 967
2022
Q3
$1.23M Buy
48,242
+2,900
+6% +$68K ﹤0.01% 966
2022
Q2
$921K Hold
45,342
﹤0.01% 1149
2022
Q1
$1.12M Buy
45,342
+510
+1% +$15.4K ﹤0.01% 1131
2021
Q4
$1.56M Buy
44,832
+1,390
+3% +$44.1K ﹤0.01% 1063
2021
Q3
$1.18M Buy
+43,442
New +$1.1M ﹤0.01% 1374
2020
Q4
Sell
-23,005
Closed -$339K 1857
2020
Q3
$339K Buy
+23,005
New +$415K ﹤0.01% 1600

Other funds holding ANAB